Alentis Therapeutics hat dies direkt geteilt
Switzerland isn’t just mountains and lakes, it’s also biotech! ⛰️ Last year Swiss biotech raised over $2 billion with both public and private companies contributing. Noema Pharma and Alentis Therapeutics completed the most notable financing rounds, each securing over $100 million. 💸 With companies contributing to cancer research, gene and cell therapy, and also the biology of aging, Switzerland’s biotech ecosystem is very mature. 🧑🔬 In this article, we focus on 18 biotechs based in Switzerland! ⬇️ https://lnkd.in/d_YZ2_xz #Swissbiotech #biotechinnovation #biotechfunding #genetherapy #celltherapy #biotechecosystem #biotechstartups Araris Biotech AG | CDR-Life Inc. | CUTISS AG | Endogena Therapeutics, Inc. | Engimmune Therapeutics | FoRx Therapeutics | GlycoEra AG | HAYA Therapeutics | ImmunOs Therapeutics AG | iOnctura | MUVON Therapeutics AG | NewBiologix | Nouscom | STALICLA | Synendos Therapeutics AG | TOLREMO therapeutics | Swiss Biotech Association | Switzerland Global Enterprise | Innosuisse | Biopôle Lausanne | Basel Area Business & Innovation | BioAlps - Swiss Health Valley | Swiss Personalized Health Network (SPHN)